Clinical Trials Directory

Trials / Unknown

UnknownNCT03319888

Effect of CPAP in the Worsening of Renal Function in Early Stages of Chronic Kidney Disease (CKD)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
700 (estimated)
Sponsor
Sociedad Española de Neumología y Cirugía Torácica · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Objectives: Evaluate the effect of CPAP to reduce the progression of chronic kidney disease or CKD (the decline of glomerular filtration rate is ≥ 30%) in patients with early-stage renal disease and sleep apnea syndrome (OSAS). Other objectives are; determine the prevalence of OSAS in patients with early-stage renal disease and evaluate the changes in inflamatories markers and endothelial damage, the state of KDIGO, cardiovascular events, mortality and cost-effectiveness analysis in CPAP group versus non-CPAP group patients. Methods: A prospective, multicentric, randomized and controlled study will be carried out for 3 years. Early-stage renal disease (G1-3 KDIGO) and OSAS patients will be included. The investigators will make a respiratory polygraphy to determinate OSAS (AHI ≥15/h) and after that, the investigators randomized patients in 2 groups; CPAP group and control group (non-CPAP treatment). Patients with AHI \<15/h (non-OSAS) will be the reference group and the half of these patients, randomly chosen, will be followed up at the end of the follow up. Statistic analysis: the investigators will analyze the differences in glomerular filtration rate before and after the treatment, comparing the percentage of patients with CKD progression for both groups. The investigators will use the chi square test with raw data and adjusted for confounding variables using intention to treat analysis with imputation of missing values.

Detailed description

There is a bidirectional involvement between the chronic kidney disease (CKD) and sleep apnea syndrome (OSAS). The declining of renal function, the fluid overloading and the disturbance of ventilation control could cause sleep apneas. On the other hand, the nocturnal hypoxia in patients with OSAS has been associated with changes in the renin-angiotensin system and sympathetic nervous system and production of reactive oxygen species. These findings are relationed with the deterioration of kidney function.

Conditions

Interventions

TypeNameDescription
DEVICECPAPcontinuous positive pressure in the airway
OTHERconservative treatmentconservative treatment group with lifestyle modifications

Timeline

Start date
2017-11-20
Primary completion
2019-11-20
Completion
2020-05-20
First posted
2017-10-24
Last updated
2018-03-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03319888. Inclusion in this directory is not an endorsement.